Table 3: Adverse events.

Adverse events
(number of patients)
Management

Urinary tract infection (3)
 Prostatitis (2)ATB (IV for 48 h than per os)
 Balanitis (1)ATB (Topical)
Acute urinary retention (1)
 Tissue sloughingIndwelling urinary catheter one month
Lower urinary tract symptoms (5)
 Voiding LUTS (2)Spontaneous resolution
 Storage LUTS (3)1 patient long term anticholinergics
Hematuria (5)Oral hydration
Urethral stricture (1)Optical urethrotomy
Incontinence (2)
 Urge incontinenceSpontaneous resolution
 Stress urinary incontinenceSpontaneous resolution
Erectile dysfunction (4)PDE5I* or intracavernous injection

PDE5I: Phosphodiesterase type 5 inhibitors.